Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven T Chen

Showing results (101-110 of 153) with videos related to

Pageof 16
Sort By:
Journal of the American Academy of Dermatology|February 3, 2023
Noncutaneous immune-related adverse events predict overall and progression-free survival in patients with cutaneous toxicities after immune checkpoint inhibitor therapyMaria S Asdourian, Ted V Jacoby, Nishi Shah, et al.
Journal of the American Academy of Dermatology|June 23, 2022
Development of multiple cutaneous immune-related adverse events among cancer patients after immune checkpoint blockadeMaria S Asdourian, Nishi Shah, Ted V Jacoby, et al.
Journal of the American Academy of Dermatology|December 19, 2025
Clinical characteristics driving hospitalization among cutaneous T-cell lymphoma patients: A six-year retrospective cohort studyMichael J Chen, Katherine Perlman, Bethany Brumbaugh, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 9, 2023
Mogamulizumab for Treatment of Human T-lymphotropic Virus Type 1-Associated Myelopathy/Tropical Spastic Paraparesis: A Single-Center US-based SeriesEric A Meyerowitz, Shibani S Mukerji, G Kyle Harrold, et al.
International Journal of Dermatology|October 29, 2025
Climate Change: An Unrecognized Threat to Yaws EradicationGhida El Banna, Natalie Baker, Kelly Li, et al.
European Journal of Cancer (Oxford, England : 1990)|February 19, 2021
Patterns and prognostic significance of cutaneous immune-related adverse events in non-small cell lung cancerLeah L Thompson, Emily R Nadelmann, Amy E Blum, et al.
Journal of the American Academy of Dermatology|February 10, 2024
Associations between dermatologic immune-related adverse event morphologies and systemic immunomodulatory/immunosuppressive treatment: A large retrospective cohort studyRachel M Reardon, Katherine L Perlman, Maria S Asdourian, et al.
Journal of the American Academy of Dermatology|April 20, 2021
Association between common medication triggers and severity of cutaneous immune-related adverse eventsMichael S Chang, Leah L Thompson, Rachel Reardon, et al.
The European Respiratory Journal|June 19, 2025
Dupilumab and lymphoma risk among patients with asthma: a population-based cohort studyKevin Sheng-Kai Ma, Bethany Brumbaugh, Rebecca R Saff, et al.
Journal of the American Academy of Dermatology|December 17, 2022
Monkeypox outbreak, vaccination, and treatment implications for the dermatologic patient: Review and interim guidance from the Medical Dermatology SocietyAnusha M Kumar, Steven T Chen, Joseph F Merola, et al.
Pageof 16

Showing results (101-110 of 153) with videos related to

Sort By:
Pageof 16
Journal of the American Academy of Dermatology|February 3, 2023
Noncutaneous immune-related adverse events predict overall and progression-free survival in patients with cutaneous toxicities after immune checkpoint inhibitor therapyMaria S Asdourian, Ted V Jacoby, Nishi Shah, et al.
Journal of the American Academy of Dermatology|June 23, 2022
Development of multiple cutaneous immune-related adverse events among cancer patients after immune checkpoint blockadeMaria S Asdourian, Nishi Shah, Ted V Jacoby, et al.
Journal of the American Academy of Dermatology|December 19, 2025
Clinical characteristics driving hospitalization among cutaneous T-cell lymphoma patients: A six-year retrospective cohort studyMichael J Chen, Katherine Perlman, Bethany Brumbaugh, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 9, 2023
Mogamulizumab for Treatment of Human T-lymphotropic Virus Type 1-Associated Myelopathy/Tropical Spastic Paraparesis: A Single-Center US-based SeriesEric A Meyerowitz, Shibani S Mukerji, G Kyle Harrold, et al.
International Journal of Dermatology|October 29, 2025
Climate Change: An Unrecognized Threat to Yaws EradicationGhida El Banna, Natalie Baker, Kelly Li, et al.
European Journal of Cancer (Oxford, England : 1990)|February 19, 2021
Patterns and prognostic significance of cutaneous immune-related adverse events in non-small cell lung cancerLeah L Thompson, Emily R Nadelmann, Amy E Blum, et al.
Journal of the American Academy of Dermatology|February 10, 2024
Associations between dermatologic immune-related adverse event morphologies and systemic immunomodulatory/immunosuppressive treatment: A large retrospective cohort studyRachel M Reardon, Katherine L Perlman, Maria S Asdourian, et al.
Journal of the American Academy of Dermatology|April 20, 2021
Association between common medication triggers and severity of cutaneous immune-related adverse eventsMichael S Chang, Leah L Thompson, Rachel Reardon, et al.
The European Respiratory Journal|June 19, 2025
Dupilumab and lymphoma risk among patients with asthma: a population-based cohort studyKevin Sheng-Kai Ma, Bethany Brumbaugh, Rebecca R Saff, et al.
Journal of the American Academy of Dermatology|December 17, 2022
Monkeypox outbreak, vaccination, and treatment implications for the dermatologic patient: Review and interim guidance from the Medical Dermatology SocietyAnusha M Kumar, Steven T Chen, Joseph F Merola, et al.
Pageof 16